In our retrospective observational study on patients affected by severe COVID-19 pneumonia and sepsis admitted to ICU, the treatment with IgM and IgA enriched IgG infusion in addition to the standard therapy resulted in a higher survival rate compared to standard therapy only. This evidence concerns the gene CD79A and Sepsis.